Be the most trusted biotech company

Shanghai Henlius CEO Wants To Capitalize On First-Mover Status

Generics Bulletin


In an exclusive interview with Generics Bulletin, Dr. Scott Liu, co-founder, and CEO of Chinese biosimilars and biologics specialist Shanghai Henlius Biotech, has set out his vision for the firm’s future in China and around the globe.

You may get more information by accessing the link below: